Gut Liver.  2014 May;8(3):265-270.

Acute Pancreatitis Secondary to Ciprofloxacin Therapy in Patients with Infectious Colitis

Affiliations
  • 1Department of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea. jikim@catholic.ac.kr

Abstract

BACKGROUND/AIMS
Ciprofloxacin is considered to be a safe and effective treatment for acute infectious colitis. However, this drug may cause drug-induced pancreatitis, albeit rarely.
METHODS
From March 2007 to February 2012, we studied 227 patients who were hospitalized for infectious colitis at St. Mary's Hospital. All of the patients received ciprofloxacin therapy for the treatment of infectious colitis. We observed a few cases of rare adverse events, including ciprofloxacin-induced acute pancreatitis diagnosed based on the Naranjo algorithm.
RESULTS
During ciprofloxacin therapy, seven of 227 patients (3.1%) developed rare pancreatitis as defined by the Naranjo algorithm; pancreatic enzyme activity was sporadically elevated with ciprofloxacin use. After ciprofloxacin administration, the average interval until the development of pancreatitis was 5.5 days (range, 4 to 7 days). On abdominal computed tomography, pancreatic swelling and homogenous enhancement was noted in three of seven patients. Complicating acute pancreatitis was gradually but completely resolved after cessation of ciprofloxacin administration. The mean recovery time was 11.3 days (range, 8 to 15 days).
CONCLUSIONS
We observed that ciprofloxacin-induced pancreatitis may occur with an incidence of approximately 3%. Ciprofloxacin-induced pancreatitis presents a short latency, suggesting an idiosyncratic hypersensitivity reaction. Practitioners should be aware that drug-induced pancreatitis can occur during ciprofloxacin therapy.

Keyword

Anti-bacterial agents; Pancreatitis; Drug toxicity; Infectious colitis

MeSH Terms

Acute Disease
Adolescent
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents/*adverse effects
Bacterial Infections/*drug therapy
Ciprofloxacin/*adverse effects
Colitis/*drug therapy
Enzyme Inhibitors/therapeutic use
Female
Gabexate/analogs & derivatives/therapeutic use
Humans
Male
Middle Aged
Pancreatitis/*chemically induced/drug therapy
Young Adult
Anti-Bacterial Agents
Ciprofloxacin
Enzyme Inhibitors
Gabexate
Full Text Links
  • GNL
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr